Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells

Placenta-derived decidua stromal cells (DSCs) are being investigated as an alternative to other sources of mesenchymal stromal cells (MSCs) for cellular therapy. DSCs are more effective in treating acute inflammatory diseases in human and this is our preclinical safety study of human DSCs in Sprague...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Behnam, Moretti, Gianluca, Arnberg, Fabian, Samén, Erik, Kohein, Bita, Catar, Rusan, Kamhieh-Milz, Julian, Geissler, Sven, Moll, Guido, Holmin, Staffan, Ringdén, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877599/
https://www.ncbi.nlm.nih.gov/pubmed/31803191
http://dx.doi.org/10.3389/fimmu.2019.02685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877599/
https://www.ncbi.nlm.nih.gov/pubmed/31803191
http://dx.doi.org/10.3389/fimmu.2019.02685

Ejemplares similares